Lynparza 100mg Tablet

What is Lynparza 100 mg

Lynparza 100 mg contains Olaparib as its active ingredient. This targeted therapy belongs to the PARP inhibitor class, and AstraZeneca manufactures this oncology medication.

This oral anticancer agent specifically targets BRCA-mutated cancers. However, it is also effective against some non-BRCA mutated cancers.

Olaparib blocks DNA repair mechanisms in cancer cells. The medication prevents tumor cells from fixing their damaged genetic material, leading to cancer cell death.

Healthcare providers prescribe this therapy for specific types of Ovarian Cancer. Breast Cancer and Prostate Cancer patients with BRCA mutations also benefit from treatment. Pancreatic Cancer treatment represents another approved indication.

Common side effects include fatigue, nausea, and decreased appetite. Blood count changes may occur during therapy. Regular monitoring ensures patient safety throughout treatment. Store Lynparza tablets at room temperature, away from moisture. Keep the medication in its original packaging until use. Children should not access this prescription medicine.

Patients must follow an oncologist's instructions precisely. Treatment duration varies based on individual response. Regular blood tests monitor treatment effectiveness and safety parameters.

What are the benefits of Lynparza 100 mg

Lynparza 100 mg delivers targeted cancer therapy through PARP inhibition. Olaparib specifically targets cancer cells with defective DNA repair systems.

The medication offers significant benefits for BRCA-positive cancers:

• Extends progression-free survival in Ovarian Cancer patients.
• Reduces tumor growth in advanced Breast Cancer cases.
• Provides treatment options for Pancreatic Cancer with specific mutations.
• Offers oral administration convenience compared to infusion therapies.

Clinical studies demonstrate improved outcomes for patients with hereditary cancer syndromes. The drug works particularly well in platinum-sensitive cancers. Maintenance therapy helps prevent cancer recurrence after the initial treatment response.

Treatment allows patients to maintain their quality of life during therapy. The oral formulation enables home-based treatment administration.

How to take Lynparza 100 mg

Lynparza is a prescription medication requiring oncologist supervision. Follow these administration guidelines:

• Take tablets twice daily as prescribed by your doctor.
• Swallow whole with water without crushing or chewing.
• Food intake does not significantly affect absorption. Maintain consistent timing between morning and evening doses.
• Do not exceed the prescribed dosage or modify the schedule independently.

Strengths and substitutes

The strengths and substitutes available at Cheap Medicine Shop are:

View all substitutes

What are the side effects of Lynparza 100 mg

Lynparza is generally manageable under medical supervision. However, side effects may include:

• Fatigue
• Weakness
• Nausea
• Vomiting
• Decreased appetite
• Low blood cell counts

These effects typically improve as treatment continues. Regular monitoring helps manage any complications effectively.

Safety Advice

Liver disease

Patients with liver impairment require careful and frequent monitoring. Hepatic function tests should be performed regularly during treatment. Severe liver disease may necessitate caution. Ask a doctor for safety advice.

Kidney impairment

Moderate kidney dysfunction requires dose modification based on creatinine clearance levels. Severe renal impairment patients need alternative treatment options. Regular kidney function monitoring ensures safe therapy continuation throughout treatment duration. Do not use it without a doctor's prescription.

Pregnant and breastfeeding women

Lynparza causes severe birth defects and should never be used during pregnancy. Women must use effective contraception during treatment and for 6 months afterward. Breastfeeding mothers should discontinue nursing before starting therapy.

Avoid

Avoid grapefruit juice as it increases drug concentration dangerously. Alcohol consumption should be limited during treatment. Strong CYP3A inhibitors require dose adjustments. Avoid live vaccines during the therapy period.